BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 28895169)

  • 1. We have had a gutful: The need for deprescribing proton pump inhibitors.
    Naunton M; Peterson GM; Deeks LS; Young H; Kosari S
    J Clin Pharm Ther; 2018 Feb; 43(1):65-72. PubMed ID: 28895169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a Proton Pump Inhibitor Deprescribing Guideline on Drug Usage and Costs in Long-Term Care.
    Thompson W; Hogel M; Li Y; Thavorn K; O'Donnell D; McCarthy L; Dolovich L; Black C; Farrell B
    J Am Med Dir Assoc; 2016 Jul; 17(7):673.e1-4. PubMed ID: 27289201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-Value Proton Pump Inhibitor Prescriptions Among Older Adults at a Large Academic Health System.
    Mafi JN; May FP; Kahn KL; Chong M; Corona E; Yang L; Mongare MM; Nair V; Reynolds C; Gupta R; Damberg CL; Esrailian E; Sarkisian C
    J Am Geriatr Soc; 2019 Dec; 67(12):2600-2604. PubMed ID: 31486549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deprescribing in a family health team: a study of chronic proton pump inhibitor use.
    Walsh K; Kwan D; Marr P; Papoushek C; Lyon WK
    J Prim Health Care; 2016 Jun; 8(2):164-71. PubMed ID: 27477559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and Implementation of a Pharmacist-Led Proton Pump Inhibitor Deprescribing Algorithm in a Geriatric Ambulatory Office.
    Leszcynski L; Bente J
    Sr Care Pharm; 2023 Mar; 38(3):105-112. PubMed ID: 36803698
    [No Abstract]   [Full Text] [Related]  

  • 6. Effectiveness of a multi-faceted intervention to deprescribe proton pump inhibitors in primary care: protocol for a population-based, pragmatic, cluster-randomized controlled trial.
    Nguyen-Soenen J; Rat C; Gaultier A; Schirr-Bonnans S; Tessier P; Fournier JP
    BMC Health Serv Res; 2022 Feb; 22(1):219. PubMed ID: 35177042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient and Provider Perspectives on Deprescribing Proton Pump Inhibitors.
    Ikeji C; Williams A; Hennawi G; Brandt NJ
    J Gerontol Nurs; 2019 Oct; 45(10):9-17. PubMed ID: 31560071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deprescribing proton pump inhibitors.
    Turner JP; Thompson W; Reeve E; Bell JS
    Aust J Gen Pract; 2022 Nov; 51(11):845-848. PubMed ID: 36310001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do recent reports about the adverse effects of proton pump inhibitors change providers' prescription practice?
    Al-Qaisi MT; Kahn A; Crowell MD; Burdick GE; Vela MF; Ramirez FC
    Dis Esophagus; 2018 Dec; 31(12):. PubMed ID: 29873678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence-based deprescribing of proton pump inhibitors in long-term care.
    Sluggett JK; Hendrix I; Bell JS
    Res Social Adm Pharm; 2018 Feb; 14(2):124-126. PubMed ID: 28424148
    [No Abstract]   [Full Text] [Related]  

  • 11. Inappropriate utilization of intravenous proton pump inhibitors in hospital practice--a prospective study of the extent of the problem and predictive factors.
    Craig DG; Thimappa R; Anand V; Sebastian S
    QJM; 2010 May; 103(5):327-35. PubMed ID: 20211846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Problems Associated with Deprescribing of Proton Pump Inhibitors.
    Helgadottir H; Bjornsson ES
    Int J Mol Sci; 2019 Nov; 20(21):. PubMed ID: 31684070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterizing Potentially Inappropriate Prescribing of Proton Pump Inhibitors in Older People in Primary Care in Ireland from 1997 to 2012.
    Moriarty F; Bennett K; Cahir C; Fahey T
    J Am Geriatr Soc; 2016 Dec; 64(12):e291-e296. PubMed ID: 27996115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inappropriate proton-pump inhibitor prescribing in primary care - an observational study with quality circles.
    Vidonscky Lüthold R; Henz NC; Fuhrer C; Häner A; Schenk M; Jungo KT; Streit S
    Swiss Med Wkly; 2023 Sep; 153():40119. PubMed ID: 37769322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prescribing, deprescribing and potential adverse effects of proton pump inhibitors in older patients with multimorbidity: an observational study.
    Aubert CE; Blum MR; Gastens V; Dalleur O; Vaillant F; Jennings E; Aujesky D; Thompson W; Kool T; Kramers C; Knol W; O'Mahony D; Rodondi N
    CMAJ Open; 2023; 11(1):E170-E178. PubMed ID: 36854455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of and interventions for Proton Pump Inhibitor prescription behavior: A systematic scoping review.
    van Gestel LC; Adriaanse MA; Kanis SL; Mensink-Bout SM; Schoones JW; Numans ME; Kiefte-de Jong JC; van den Brink G
    BMC Prim Care; 2024 Jun; 25(1):208. PubMed ID: 38862886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of Interventions to Deprescribe Inappropriate Proton Pump Inhibitors in Older Adults.
    Wilsdon TD; Hendrix I; Thynne TR; Mangoni AA
    Drugs Aging; 2017 Apr; 34(4):265-287. PubMed ID: 28220380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deprescribing proton pump inhibitors: Evidence-based clinical practice guideline.
    Farrell B; Pottie K; Thompson W; Boghossian T; Pizzola L; Rashid FJ; Rojas-Fernandez C; Walsh K; Welch V; Moayyedi P
    Can Fam Physician; 2017 May; 63(5):354-364. PubMed ID: 28500192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is there a role for proton pump inhibitor prophylaxis in haematology patients?
    Leitinger E; Hui L; Grigg A
    Intern Med J; 2019 Jun; 49(6):694-701. PubMed ID: 30719802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Use and Misuse of Proton Pump Inhibitors: An Opportunity for Deprescribing.
    Dharmarajan TS
    J Am Med Dir Assoc; 2021 Jan; 22(1):15-22. PubMed ID: 33321078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.